BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026

  October 27, 2026

   · 

  5 min read
• Press Releases

  Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome, with new preclinical and epidemiological data presented at ASN Kidney Week 2026

  October 27, 2026

   · 

  9 min read
• Press Releases

  Avanzanite Bioscience Expands UK Presence and Appoints Sarah O’Connell as Country Manager

  October 27, 2026

   · 

  2 min read
• Press Releases

  Fangzhou’s AI-Powered Supply Chain Platform Recognized in 2026 for Pharmaceutical Distribution Best Practices

  October 27, 2026

   · 

  3 min read
• Press Releases

  Enhertu® Approved in the EU as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer

  October 27, 2026

   · 

  13 min read
• Press Releases

  Cantargia to Present at the Stifel 2026 Healthcare Conference

  October 27, 2026

   · 

  1 min read
• Press Releases

  Henlius reports positive results from ASTRIDE U.S. bridging study for serplulimab in combination with chemotherapy for first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC)

  October 27, 2026

   · 

  6 min read
• Press Releases

  National Leader in Cancer Symptom Management, Ishwaria Subbiah, MD, Joins Perlmutter Cancer Center

  October 27, 2026

   · 

  5 min read
• Press Releases

  Aclaris Therapeutics Announces Positive Phase 1b Proof-of-Concept Primary Analysis Results for its Anti-TSLP/IL-4Rα Bispecific ATI-052 in Atopic Dermatitis (AD) and Asthma

  October 27, 2026

   · 

  12 min read
• Press Releases

  Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026

  October 27, 2026

   · 

  3 min read